Inclusive of all taxes
Auriliv is an advanced hepatoprotective formulation combining Silybum marianum (Milk Thistle) and Andrographis paniculata in a cutting-edge Nanophosphosome® delivery system. This nano-emulsified complex significantly enhances the bioavailability and cellular transport of the active compounds, including silymarin and andrographolide, through its patented phosphatidylcholine-serine-ethanolamine matrix. Auriliv leverages proprietary bioenhancer and metabolic potentiator technology to optimize intestinal absorption by facilitating both passive diffusion and active transport across intestinal microvilli. Furthermore, it inhibits key metabolic enzymes such as CYP3A4, CYP3AG, UGT, and P-glycoprotein efflux pumps, thereby preventing premature metabolic degradation. This targeted action ensures improved plasma concentration and sustained release of liver-supporting phytochemicals, making Auriliv an ideal nutraceutical for enhancing liver detoxification, protecting hepatocytes from oxidative stress, and promoting overall liver health. Recommended for pharmaceutical companies, nutraceutical manufacturers, and healthcare professionals seeking a highly bioavailable liver support ingredient with scientifically validated metabolic modulation.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Silybum marianum (Milk Thistle) and Andrographis paniculata |
| Delivery System | Nanophosphosome® nano-emulsified complex |
| Bioenhancer Technology | Advanced bioenhancers to improve absorption and cellular transport |
| Metabolic Potentiator | Inhibits metabolic enzymes and efflux pumps (CYP3A4, CYP3AG, UGT, P-gp) |
| Mechanism of Action | Enhances passive diffusion and active transport through intestinal microvilli |
| Improved Bioavailability | Prevents metabolic reduction of active compounds, ensuring higher plasma levels |
| Therapeutic Focus | Supports liver function and hepatocyte protection |
| Formulation Benefits | Sustained release and enhanced cellular uptake |
| Intended Use | For pharmaceutical, nutraceutical, and healthcare industries |
| Technology Patented | Nanophosphosome® patented delivery system |
| Attributes | Description |
|---|---|
| Composition | Silymarin and Andrographolide complex with Phosphatidylcholine, Serine, Ethanolamine |
| Form | Nano-emulsified phospholipid complex |
| Absorption Enhancement | Inhibition of P-gp efflux, ATPase, CYP3A4, CYP3AG, UGT enzyme pathways |
| Targeted Organ | Liver |
| Dosage Form Compatibility | Suitable for incorporation into capsules, tablets, liquid formulations |
| Mechanism | Enhances active constituent permeability and metabolic stability |
| Stability | Enhanced stability due to nano-emulsification |
| Storage | Store in cool, dry place away from direct sunlight |
| Shelf Life | Typically 24 months when stored properly |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Auriliv uses a proprietary Nanophosphosome® nano-emulsified delivery system combined with bioenhancer technology that facilitates both passive diffusion and active transport across intestinal microvilli while inhibiting metabolic enzymes and efflux pumps responsible for drug degradation, thereby significantly enhancing the bioavailability of its active compounds.
The metabolic potentiator technology in Auriliv inhibits key enzymes like CYP3A4, CYP3AG, UGT, and the P-glycoprotein efflux pump, which typically metabolize and reduce the concentration of active phytochemicals, prolonging their presence in systemic circulation and increasing therapeutic efficacy.
Yes, Auriliv’s nano-emulsified Nanophosphosome® complex is stable and compatible with various dosage forms including capsules, tablets, and liquid nutraceutical products, allowing versatile application in pharmaceutical and nutraceutical manufacturing.
Unlike regular extracts, Auriliv combines both herbal actives into a patented nano-emulsified phospholipid complex with advanced bioenhancer and metabolic potentiator technologies, which significantly improves absorption, reduces metabolic loss, and promotes higher bioavailability, enhancing its liver support effects.
Auriliv prevents metabolic reduction by inhibiting P-glycoprotein efflux pumps and metabolizing enzymes such as CYP3A4, CYP3AG, and UGT, which are responsible for the breakdown and clearance of silymarin and andrographolide, thus ensuring sustained therapeutic levels.
Brand: aurinko
Country Of Origin: India
Auriliv is a synergistic combination of Silybum marianum and Andrographis paniculata Nanophosphosome® (a nano- emulsified Silymarin - Andrographolide Phosphatidyl Choline - Serine - Ethanolamine complex) with technologically advanced bioenhancer and metabolic potentiator technology.Bioenhancer and metabolic activator technology enhances the passive diffusion and active transport mechanism through intestinal microvilli to improve actives’ absorption as well prevents their metabolic reduction through inhibition of P - gp efflux pump, ATPase activity, CYP3A4, CYP3AG and UGT
Inclusive of all taxes
You Save: 0
